104 related articles for article (PubMed ID: 3825447)
1. [Propranolol and portal hypertension in cirrhotic patients. Manometric and hemodynamic studies].
Reding P; Urbain D; Frère D; Thys O; Grivegnée A
Acta Gastroenterol Belg; 1986; 49(3):324-8. PubMed ID: 3825447
[No Abstract] [Full Text] [Related]
2. [The use of anaprilin for the correction of portal hypertension in liver cirrhosis].
Bondarenko IP; Dubinskiĭ AA; Tereshkin IG
Vrach Delo; 1989 Nov; (11):19-22. PubMed ID: 2609578
[TBL] [Abstract][Full Text] [Related]
3. [Rheohepatographic assessment of the therapeutic effects of propranolol on portal hypertension].
Wu XN
Zhonghua Yi Xue Za Zhi; 1985 Jul; 65(7):411-3, 446. PubMed ID: 3938325
[No Abstract] [Full Text] [Related]
4. Long term effects of propranolol on portal pressure in cirrhotic patients.
Orban-Schiopu AM; Popescu CR
Rom J Gastroenterol; 2003 Mar; 12(1):25-30. PubMed ID: 12673376
[TBL] [Abstract][Full Text] [Related]
5. Hemodynamic response to propranolol in patients with recurrent hepatitis C virus-related cirrhosis after liver transplantation: a case-control study.
Schepis F; Vukotic R; Berzigotti A; Carrión JA; Forns X; Abraldes JG; García-Valdecasas JC; Navasa M; García-Pagán JC; Bosch J
Liver Transpl; 2013 Apr; 19(4):450-6. PubMed ID: 23408436
[TBL] [Abstract][Full Text] [Related]
6. Comparative randomized study on efficacy of losartan versus propranolol in lowering portal pressure in decompensated chronic liver disease.
Agasti AK; Mahajan AU; Phadke AY; Nathani PJ; Sawant P
J Dig Dis; 2013 May; 14(5):266-71. PubMed ID: 23280243
[TBL] [Abstract][Full Text] [Related]
7. [Drug treatment for portal hypertension due to cirrhosis].
Lebrec D; Benhamou JP
Gastroenterol Clin Biol; 1982; 6(6-7):542-8. PubMed ID: 6126417
[No Abstract] [Full Text] [Related]
8. The haemodynamic response to propranolol in cirrhosis with arterial hypertension: a comparative analysis with normotensive cirrhotic patients.
Sharma P; Kumar A; Jha S; Mishra SR; Sharma BC; Sarin SK
Aliment Pharmacol Ther; 2010 Jul; 32(1):105-12. PubMed ID: 20345511
[TBL] [Abstract][Full Text] [Related]
9. [Drug therapy of pulmonary and portal hypertension in liver cirrhosis].
Vorob'ev LP; Maev IV; Andreev NG
Klin Med (Mosk); 1991 Feb; 69(2):64-7. PubMed ID: 1875666
[TBL] [Abstract][Full Text] [Related]
10. Beta-blockers.
Bursey RF
Can J Gastroenterol; 1998; 12(8):542-3. PubMed ID: 9926263
[No Abstract] [Full Text] [Related]
11. Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis.
Bañares R; Moitinho E; Piqueras B; Casado M; García-Pagán JC; de Diego A; Bosch J
Hepatology; 1999 Jul; 30(1):79-83. PubMed ID: 10385642
[TBL] [Abstract][Full Text] [Related]
12. Portal pressure response to losartan compared with propranolol in patients with cirrhosis.
De BK; Bandyopadhyay K; Das TK; Das D; Biswas PK; Majumdar D; Mandal SK; Ray S; Dasgupta S
Am J Gastroenterol; 2003 Jun; 98(6):1371-6. PubMed ID: 12818283
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic effect of propranolol on portal hypertension in patients with HBsAg-positive cirrhosis.
Kong CW; Lay CS; Tsai YT; Lee SD; Lai KH; Lo KJ; Chiang BN
Dig Dis Sci; 1986 Dec; 31(12):1303-6. PubMed ID: 3803132
[TBL] [Abstract][Full Text] [Related]
14. [Effects of propranolol in the patient with liver cirrhosis and hemorrhage caused by esophageal varices].
Esquivel López A; López Fuertes F; Perches Vega A; Salgado-Escobar JL
Rev Gastroenterol Mex; 1984; 49(4):211-4. PubMed ID: 6335774
[No Abstract] [Full Text] [Related]
15. Assessment of effects of propranolol on portal hemodynamics in cirrhosis by duplex ultrasonography.
Saigal S; Chawla Y; Dilawari JB
Indian J Gastroenterol; 1998 Apr; 17(2):51-2. PubMed ID: 9563219
[TBL] [Abstract][Full Text] [Related]
16. Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding.
Villanueva C; Aracil C; Colomo A; Hernández-Gea V; López-Balaguer JM; Alvarez-Urturi C; Torras X; Balanzó J; Guarner C
Gastroenterology; 2009 Jul; 137(1):119-28. PubMed ID: 19344721
[TBL] [Abstract][Full Text] [Related]
17. Drug therapy of portal hypertension due to cirrhosis.
Benhamou JP; Lebrec D
Semin Liver Dis; 1982 Aug; 2(3):227-32. PubMed ID: 6129706
[No Abstract] [Full Text] [Related]
18. Propranolol treatment of portal hypertension in cirrhosis patients is better the higher the untreated pressure: a single-centre prospective experience.
Heebøll S; Villadsen GE; Aagaard NK; Grønbæk H; Vilstrup H; Keiding S
Scand J Gastroenterol; 2013 Aug; 48(8):969-73. PubMed ID: 23755897
[TBL] [Abstract][Full Text] [Related]
19. Effects of carvedilol and propranolol on circulatory regulation and oxygenation in cirrhosis: a randomised study.
Hobolth L; Bendtsen F; Hansen EF; Møller S
Dig Liver Dis; 2014 Mar; 46(3):251-6. PubMed ID: 24290869
[TBL] [Abstract][Full Text] [Related]
20. [Physiopathological bases of the medical treatment of portal hypertension].
Cuccurullo F; Seccia G; Porreca E; Guglielmi MD; Mezzetti A; Tomassetti V; Marzio L
G Clin Med; 1982 Oct; 63(10):737-43. PubMed ID: 7182198
[No Abstract] [Full Text] [Related]
[Next] [New Search]
